With the cancer vaccines that Gradalis are working on, it is individualised treatments, with the patient's tumors being used to develop the best treatment in conjunction with the bi-shRNA, with injections for up to 12 months. There is big money in this for big pharma. Better to have someone being treated successfully for a year with these treatment that may actually bring about a cure than treating them with chemo and radiation for a year and they die early anyway.
BLT Price at posting:
65.0¢ Sentiment: Hold Disclosure: Held